摘要
目的探讨右美托咪定防治肺叶切除术后谵妄的价值。方法随机选取我院接受肺叶切除手术的110例患者为分析病例,随机分为研究组(应用右美托咪定)和对照组(应用安慰剂)各55例,对比分析两组谵妄发生情况。结果两组间手术时间、药物应用剂量等无明显差异,但是研究组苏醒期谵妄发生率(9.09%)和术后谵妄发生率(29.09%)均明显低于对照组,经统计学分析,P<0.05具有显著性差异。结论右美托咪定有利于降低肺叶切除术患者发生谵妄的危险性,值得推广。
Objective To discuss the treatment value of dexmedetomidine for the postoperative delirium patients after lung lobectomy .Methods 1 1 0 patients with lung lobectomy were randomly selected in our hospi -tal as the objects .They were randomly divided into study group （dexmedetomidine group ） and control group （placebo） ,there were 5 5 cases in each group .The incidence of delirium was compared between two groups .Re-sults In study group ,the waking period delirium rate and postoperative delirium incidence were significantly lower than that of the control group ,after statistical analysis ,P 〈 0 .0 5 ,there were significant differences .Con-clusions Dexmedetomidine can reduce the risk of delirium for the patients with lung lobectomy ,it is worth promoting .
出处
《内蒙古医学杂志》
2016年第6期677-678,共2页
Inner Mongolia Medical Journal
关键词
右美托咪定
肺叶切除术
谵妄
dexmedetomidine
lung lobectomy
postoperative delirium
